Reference Material Supply

Reference materials are the "metrological yardstick" of pharmaceutical quality control. STD holds dual CNAS accreditations — 17034 reference-material producer and 17025 testing laboratory — and independently develops and manufactures reference standards and quality-control samples with a complete metrological traceability chain. Every batch ships with a full COA, providing traceable quantitative benchmarks for pharmaceutical QC and impurity research.

Reference Materials Supply Dual CNASClosed-loop Traceability

Inquire Now
  • 资质闭环:同步持有 CNAS 17034 标准物质生产、CNAS 17025 检测实验室双项认可,自研制备与检测标定全流程自主管控,无外包数据断点,为国内申报与海外注册提供权威资质支撑。

  • 计量溯源:依托 17034 规范搭建完整计量溯源链,量值可追溯至国家计量基准;搭配 17025 实验室完成均匀性、稳定性全项验证,原始数据长期存档,全面满足 GMP、药监核查溯源要求。

  • 合规报告:COA 分析报告由自有认可实验室独立出具,配套完整图谱、不确定度评估原始记录,无需二次复测,直接用于药品注册、一致性评价申报。

  • 一体化技术服务:打通现货标准品供应、杂质定向合成、结构确证、定值标定全链条服务,双体系协同完成样品开发与数据验证,同步提供药典合规、方法验证配套技术支撑。

Reference Material Supply

Reference Standards

Reference standards are characterized materials with well-defined purity, molecular structure and quantitative content, providing metrological benchmarks for end-to-end pharmaceutical QC. They are widely applied in drug identification, assay of active ingredients, impurity-limit quantitation and chromatographic method calibration — core materials indispensable to pharmaceutical R&D, manufacturing and regulatory submission.

STD operates within a dual-accreditation framework (CNAS 17034 reference-material producer + CNAS 17025 testing laboratory) and independently executes the full chain of reference-standard development, synthesis, isolation and certified-value assignment. The product portfolio spans two core categories: filing-grade reference standards traceable to ChP and WHO international reference materials for high-tier quantitation; and in-house certified working standards periodically cross-checked against filing-grade benchmarks for routine QC. Custom impurity reference standards are delivered after impurity isolation, targeted synthesis, full structural confirmation and homogeneity/stability investigation, supporting generic-drug consistency evaluation and new-drug impurity profiling.

Every batch ships with a compliant COA that fully records purity, content, water content, residual solvents, storage conditions, shelf life and uncertainty assessment, accompanied by complete NMR/LC/MS raw spectra. All data is governed by the dual-CNAS control system; the metrological traceability chain is complete and auditable, supporting domestic CDE registration, overseas drug submission and on-site GMP inspection.

Test Items & Compendial Basis

Type
Core Application
Assay Grade (Mass Balance)
HPLC Purity (Area Normalization)
Metrological Traceability
Compendial Basis
杂质标准品
有关物质定性、杂质限度定量

申报用途:含量≥98.0%

研发预实验:含量≥95.0%

≥99.0%
合成/分离制备,完成结构确证(NMR/HRMS)、含量赋值(质量平衡法)、均匀性考察

ChP 9102、

ICH Q3A/B

降解杂质对照品
药品稳定性考察杂质研究

申报用途:含量≥98.0%

研发预实验:含量≥95.0%

≥99.0%
强制降解分离,配套完整结构解析与含量赋值数据

ChP 9102、

ICH Q1A

代谢物标准品
体内药分、生物样本、BE试验分析

申报用途:含量≥98.0%

研发预实验:含量≥95.0%

≥99.0%
合成/生物转化制备,全套结构确证与含量标定

ChP 9011、FDA Bioanalytical Method Validation Guidance

Technical Specifications

分级纯度管控:

高纯度标准品(HPLC纯度≥99.5%)、申报级杂质/降解/代谢物标准品(纯度≥98%)、日常检测标准品(纯度≥95%),纯度均经质量平衡法或面积归一法赋值,附不确定度评估。

合规 COA:

每批出具中英文COA分析报告,附全套检测图谱(HPLC/GC/NMR/HRMS)、稳定性与溯源原始数据,报告内容符合ICH Q2及ChP通则要求,可直接用于药品申报与GMP核查。

灵活分装:

常规现货规格10mg/50mg/100mg,支持微量分装及混合标样定制,满足不同实验需求。

完整稳定性验证:

储存条件与有效期经长期(≥12个月)及加速(40℃/75%RH)稳定性试验确认,数据长效存档,保障批次间一致性。

全链路计量溯源:

量值溯源至国家/国际法定基准(如中检院对照品、USP/EP标准品),定期与法定标准品比对,溯源档案完整可查。

双 CNAS 体系闭环:

自研制备、检测定值全流程在CNAS 17034与17025双体系管控下自主完成,规避外包数据断点与审计风险。

Application Scenarios

01 原料药含量测定

在 HPLC 含量测定中,以标准品为对照建立校准曲线(外标法/内标法),精确定量原料药中主成分的含量,是药品放行检验的核心指标。

02 有关物质定量

使用杂质标准品作为对照,对原料药或制剂中的已知杂质进行准确定量,根据ICH Q3A(原料药)或Q3B(制剂)的阈值要求判断是否超出报告阈值或限度。

03 鉴别试验

通过标准品与供试品的保留时间比对(HPLC/GC)、红外光谱比对(IR)或比移值比对(TLC),确认药品身份。

04 稳定性考察

在药品有效期内的长期/加速稳定性研究中,使用同一批次标准品为对照,监测含量变化和降解产物增长趋势,支撑有效期确定与包装选择。

05 方法验证系统适用性

分析方法验证前,以标准品运行系统适用性试验(SST),确认色谱系统的分离度、理论塔板数、拖尾因子等满足方法要求。

06 仿制药一致性评价

仿制药与参比制剂的体外溶出曲线比对、杂质谱对比研究中,需使用同一批标准品确保检测结果的可比性与一致性。


CHINA NATIONAL STANDARD PHARMACEUTICAL CORPORATION LIMITED

Standard R&D Pharmaceutical Reference Material Tech (Beijing) Co., Ltd. | Standard R&D Pharmaceutical Reference Material Tech (Shanghai) Co., Ltd. | Standard Pharmaceutical Reference Material R&D (Shenzhen) Co., Ltd.

Standard Pharmaceutical Standard Technical Service (Nanjing) Co., Ltd. | Standard Pharmaceutical Reference Material R&D (Hubei) Co., Ltd. | Standard (Shenzhen) Pharmaceutical R&D Co., Ltd. | Standard Pharmaceutical Information Tech (Hubei) Co., Ltd.

Hubei ICP License 2022001649